相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。A Randomized, Open-Label, Phase II Study Comparing Pemetrexed Plus Cisplatin Followed by Maintenance Pemetrexed versus Pemetrexed Alone in Patients with Epidermal Growth Factor Receptor (EGFR)-Mutant Non-small Cell Lung Cancer after Failure of First-Line EGFR Tyrosine Kinase Inhibitor: KCSG-LU12-13
Kwai Han Yoo et al.
CANCER RESEARCH AND TREATMENT (2019)
Treatment patterns, duration and outcomes of pemetrexed maintenance therapy in patients with advanced NSCLC in a real-world setting
Katherine B. Winfree et al.
CURRENT MEDICAL RESEARCH AND OPINION (2019)
Treatment Decisions for Advanced Non-Squamous Non-Small Cell Lung Cancer: Patient and Physician Perspectives on Maintenance Therapy
Suzanne McMullen et al.
PATIENT-PATIENT CENTERED OUTCOMES RESEARCH (2019)
Pemetrexed and carboplatin combination therapy followed by pemetrexed maintenance in Japanese patients with non-squamous non-small cell lung cancer: A subgroup analysis of elderly patients
Naoyuki Nogami et al.
RESPIRATORY INVESTIGATION (2019)
Pemetrexed Continuation Maintenance Phase 3 Trials in Nonsquamous, Non-Small-Cell Lung Cancer: Focus on 2-Year Overall Survival and Continuum of Care
Jyoti D. Patel et al.
CLINICAL LUNG CANCER (2018)
Renal impairment during pemetrexed maintenance in patients with advanced nonsmall cell lung cancer: a cohort study
Sabine Visser et al.
EUROPEAN RESPIRATORY JOURNAL (2018)
Third-space fluid distribution of pemetrexed in non-small cell lung cancer patients
Per Hartvig Honore et al.
CANCER CHEMOTHERAPY AND PHARMACOLOGY (2014)
Final Efficacy and Safety Results of Pemetrexed Continuation Maintenance Therapy in the Elderly from the PARAMOUNT Phase III Study
Cesare Gridelli et al.
JOURNAL OF THORACIC ONCOLOGY (2014)
Maintenance therapy with pemetrexed plus best supportive care versus placebo plus best supportive care after induction therapy with pemetrexed plus cisplatin for advanced non-squamous non-small-cell lung cancer (PARAMOUNT): a double-blind, phase 3, randomised controlled trial
Luis Paz-Ares et al.
LANCET ONCOLOGY (2012)
Pharmacokinetic evaluation of pemetrexed
Jens Benn Sorensen
EXPERT OPINION ON DRUG METABOLISM & TOXICOLOGY (2011)
Methotrexate area under the curve is an important outcome predictor in patients with primary CNS lymphoma: A pharmacokinetic-pharmacodynamic analysis from the IELSG no. 20 trial
M. Joerger et al.
BRITISH JOURNAL OF CANCER (2010)
Pemetrexed Safety and Pharmacokinetics in Patients with Third-Space Fluid
Nicolas J. Dickgreber et al.
CLINICAL CANCER RESEARCH (2010)
Maintenance pemetrexed plus best supportive care versus placebo plus best supportive care for non-small-cell lung cancer: a randomised, double-blind, phase 3 study
Tudor Ciuleanu et al.
LANCET (2009)
Phase III trial of pemetrexed plus best supportive care compared with best supportive care in previously treated patients with advanced malignant pleural mesothelioma
Jacek Jassem et al.
JOURNAL OF CLINICAL ONCOLOGY (2008)
Survival without common toxicity criteria grade 3/4 toxicity for pemetrexed compared with docetaxel in previously treated patients with advanced non-small cell lung cancer (NSCLC): A risk-benefit analysis
Jean-Louis Pujol et al.
JOURNAL OF THORACIC ONCOLOGY (2007)
A semimechanistic-physiologic population pharmacokinetic/pharmacodynamic model for neutropenia following pemetrexed therapy
J Latz et al.
CANCER CHEMOTHERAPY AND PHARMACOLOGY (2006)
Clinical application of a semimechanistic-physiologic population PK/PD model for neutropenia following pemetrexed therapy
JE Latz et al.
CANCER CHEMOTHERAPY AND PHARMACOLOGY (2006)
Phase I and pharmacokinetic study of pemetrexed administered every 3 weeks to advanced cancer patients with normal and impaired renal function
AC Mita et al.
JOURNAL OF CLINICAL ONCOLOGY (2006)
Randomized phase III trial of pemetrexed versus docetaxel in patients with non-small-cell lung cancer previously treated with chemotherapy
N Hanna et al.
JOURNAL OF CLINICAL ONCOLOGY (2004)
The effect of malignant effusions on methotrexate disposition
J Li et al.
CANCER CHEMOTHERAPY AND PHARMACOLOGY (2002)
分享论文
